Users Stopping Slimming Medications Gain Back Pounds Four Times Faster Than Dieters

New research suggests that patients who stop using new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt traditional diet and exercise programs.

Research printed in a major health publication points out that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.

"People buying these medications must be cognizant of the potential of fast rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to pre-treatment weight in about one and a half years.

Weighing Therapies

The research, which examined dozens of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with other pills.

The team emphasize that individuals who shed pounds through diet and exercise generally experience a more gradual creep back—around 100 grams monthly—after stopping.

The Reason for the Quick Regain

Experts suggest the mode of action of the drugs accounts for the amplified rebound.

These medications imitate a body's own chemical called GLP-1, which moderates appetite.

"Long-term administration of the hormone levels far above than normal may cause the body to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating much more probable."

A Lifelong Disease?

The NHS suggest the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals contend that, given the likelihood of weight regain, the treatment should be considered life-long.

This opinion is reinforced by pharmaceutical companies, who state that the results "underscore the persistent nature of excess weight," comparing it to managing diseases like hypertension.

Patient Accounts

Users who have stopped the jabs report a intense return of appetite.

"I experienced a trigger that goes on and I was suddenly ravenous," described a patient.

The struggle is exacerbated if patients have not adopted permanent lifestyle or habit changes during therapy.

Widespread Adoption

Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.

• Adoption is greater among females than males.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are powerful tools for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on integrated lifestyle changes.